Who owns ESLA?
Institutional ownership of Estrella Immunopharma Inc. from Form 13F, Q2 2026
15 institutional managers reported holding Estrella Immunopharma Inc. (ESLA) in Form 13F filings for Q2 2026, with 4,794,274 shares worth $5.0M. The largest reported holder was Armistice Capital, LLC. Managers that filed both quarters cut a net 384,550 shares (-7.4%). 2 opened new positions and 3 sold out.
- Funds holding
- 15
- Value held
- $5.0M
- New / sold out
- 2 / 3
- Net shares, same filers
- -7.4%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ESLA
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Armistice Capital, LLC | $4.1M | 82.9% | 3,975,220 | Trimmed |
| Vanguard Capital Management LLC | $434K | 8.7% | 416,852 | Added |
| Geode Capital Management, LLC | $147K | 2.9% | 141,321 | Trimmed |
| Vanguard Fiduciary Trust Co | $68K | 1.4% | 64,921 | Unchanged |
| BlackRock, Inc. | $54K | 1.1% | 52,033 | Added |
| State Street Corp | $45K | 0.9% | 43,252 | Unchanged |
| Renaissance Technologies LLC | $41K | 0.8% | 39,100 | Trimmed |
| Northern Trust Corp | $36K | 0.7% | 34,861 | Added |
| US Bancorp \de\ | $21K | 0.4% | 20,000 | Added |
| Tower Research Capital LLC (TRC) | $3K | 0.1% | 3,308 | Trimmed |
| UBS Group AG | $2K | 0.0% | 1,721 | Trimmed |
| Toronto Dominion Bank | $1K | 0.0% | 1,089 | Unchanged |
| Wolverine Asset Management LLC | $487 | 0.0% | 468 | Unchanged |
| Barclays PLC | $131 | 0.0% | 126 | New |
| Caitong International Asset Management Co., Ltd | $2 | 0.0% | 2 | New |
Share of 13F holdings is each fund's shares as a share of the 4,794,274 ESLA shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Vanguard Capital Management LLC Added+$36K
- Northern Trust Corp Added+$16K
- BlackRock, Inc. Added+$13K
- US Bancorp \de\ Added+$3K
- Barclays PLC New+$131
- Caitong International Asset Management Co., Ltd New+$2
Biggest sellers in Q2 2026
- Wells Fargo & Company Sold out-$280K
- Armistice Capital, LLC Trimmed-$129K
- Renaissance Technologies LLC Trimmed-$25K
- Geode Capital Management, LLC Trimmed-$17K
- UBS Group AG Trimmed-$14K
- Royal Bank of Canada Sold out-$7K
- Tower Research Capital LLC (TRC) Trimmed-$2K
- Morgan Stanley Sold out-$1
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $68K and sold $473K; 4 added and 5 trimmed.
Schedule 13D and 13G filings on ESLA
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-15ARMISTICE CAPITAL, LLC SCHEDULE 13G filed by Estrella Immunopharma Inc.Schedule 13G
Questions about ESLA ownership
- Who owns ESLA stock?
- 15 institutional investment managers reported ESLA positions in their Form 13F filings for Q2 2026, holding 4,794,274 shares worth $5.0M in total. Armistice Capital, LLC reported the largest position.
- Are funds buying or selling ESLA?
- In Q2 2026, 2 managers opened new ESLA positions, 4 added, 5 trimmed and 3 sold out. Managers that filed in both quarters sold a net 384,550 shares.
- How current is this ESLA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ESLA by CUSIP. Options are left out. ESLA news and filings · ESLA insider trades · Top funds